Formulation and Drug Delivery

Cesca Licenses CAR-T Cellular Processing Services to China’s Boyalife Group

March 26, 2018

The agreement gives IncoCell Tianjin, a wholly-owned subsidiary of China-based Boyalife Group, access to Cesca’s celluar processing contract development and manufacturing services.

Helix BioPharma Partners with ProMab on CAR-T Therapies

March 23, 2018

The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.

Wuxi Biologics to Install Large-Scale Single-Use Bioreactor

March 22, 2018

The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.

Testing Hard-Shell Capsules for Dry Powder Inhalers

March 19, 2018

Puncture and aerosolization tests measure the effectiveness of hard-shell capsules used in dry powder inhalers (DPIs) for inhaled drug products.

Ambr 250 High Throughput Bioreactor System Speeds Up Intensified Cell Culture Process Development

March 19, 2018

Sartorius Stedim Biotech has launched a new automated parallel bioreactor system for perfusion culture.

Nanologica and Sterling Partner on Silica Production

March 19, 2018

Nanologica AB has entered into a service agreement with CDMO Sterling Pharma Solutions for the large-scale production of silica particles.

Sensor Technology Aims to Improve Medication Adherence

March 16, 2018

Sensors and devices being developed by nGageIT Digital Health Solutions can track patient use of oral solid-dosage or injectable drugs.

USP Cancels Revisions to Packaging Chapters

March 13, 2018

Revisions to chapters on glass containers and elastomeric closures were canceled following review of comments.

Software Aids Product and Process Development for Pharmaceutical Tablets

March 09, 2018

The Natoli AIM Data Acquisition and Analytical Software for Natoli’s NP-RD10A single-station tablet press speeds research and development.

FDA's Gottlieb Hits Innovators, Insurers for Blocking Biosimilar Uptake

March 08, 2018

The FDA commissioner outlined the agency's initiatives to reward innovation and biosimilars development.